newsfilter
← Latest News
GlobeNewswire·

Osmotica Pharmaceuticals plc Announces Agreement to Settle Patent Litigation with Adamas

Adamas to acquire global rights to OSMOLEX ER® for $7.5 million Company to focus on maximizing commercial opportunity for Upneeq™ BRIDGEWATER, N.J., Dec. 02, 2020 (GLOBE NEWSWIRE) -- Osmotica...